Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000597453 | SCV000706817 | uncertain significance | not provided | 2018-05-22 | criteria provided, single submitter | clinical testing | |
Mayo Clinic Laboratories, |
RCV000597453 | SCV001714910 | uncertain significance | not provided | 2022-07-07 | criteria provided, single submitter | clinical testing | BS1 |
Invitae | RCV001376734 | SCV001719605 | benign | Hereditary fructosuria | 2023-11-13 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000597453 | SCV001800954 | uncertain significance | not provided | 2020-03-04 | criteria provided, single submitter | clinical testing | Functional studies found that this variant causes loss of transcription from the promoter (Coffee et al., 2010); Nucleotide substitution has no predicted effect on splicing and is not conserved across species; This variant is associated with the following publications: (PMID: 20882353, 25910213) |
Ce |
RCV000597453 | SCV004042363 | benign | not provided | 2023-09-01 | criteria provided, single submitter | clinical testing | ALDOB: BS1, BS2 |
ATS em Genética Clínica, |
RCV001376734 | SCV001573893 | pathogenic | Hereditary fructosuria | 2021-03-18 | no assertion criteria provided | literature only |